Director, Global RWE-HO, Oncology
Leads the planning, design, and execution of real-world evidence (RWE) and health outcomes studies to support oncology assets across the product lifecycle. Collaborates with cross-functional teams to generate robust evidence for regulatory, reimbursement, and market access decisions. Focuses on translating clinical and economic value into impactful data for payers, providers, and patients.